Le Lézard
Classified in: Health
Subjects: ASI, DEI

New York Orthopedic Surgeon Dr. Gabriel Dassa Masters Medical Field and Music Industry as America's Singing Doctor


NEW YORK, March 2, 2023 /PRNewswire/ -- Dr. Gabriel Dassa plays a leading role in both the medical world and the music industry with his unique set of skills. He is not only a well-known orthopedic expert. He also has the proud honor of being a rising star in the music industry.

From the operating room and during consults then onward to the music stage, Dr. Dassa greatly accomplishes his passions. He is the leading orthopedic expert in the New York Metropolitan area and is well known as one of the most memorable voices in the a cappella group Jay Siegel's Tokens. A trailblazer across industries, he continues to spread joy and healing in the community through both medicine and music.

The magic behind the sound of the Tokens was stylized by Jay Siegel, the original lead singer, and founding member. A distinct falsetto and tenor lead has remained sacred and characterized by the group with Dr. Dassa and Kurt Yaghjian. Most well-known for the song "The Lion Sleeps Tonight," the music continuously captivates audiences around the world.

While his practice Dassa Orthopedics specializes in orthopedic treatments, Dr. Dassa also applies the benefits of music to his overall office protocols. His patients love his musical presence as much as his delighted audiences when he performs. The doctor that does it all abides by a motto of being able to treat all patients in a competent and compassionate environment.

Musical inclinations are rooted in the revival of his own all-time favorite band. At an early age, Dr. Dassa met many artists including Robert Carr from Robert and Johnny and Willie Winfield of the Harptones to name a few. He had shared the stage with music greats such as The Drifters, The Miracles, and Righteous Brothers and many other artists from the 50's and 60's. He quickly developed a strong ardor for Doo-wop and musical expression. Simultaneously in active pursuit of medicine, he would sing between surgeries, performing in local theater productions of "Jesus Christ Superstar" and "Godspell."

The delight in the cross-connections of the fields proved to be a noteworthy affair that would last a lifetime. Within no time, Dr. Dassa received offers from the leading names in a cappella. He is a founding member of Classic Sounds who are 2-time winners of SingStrong A Cappella American Idol. On stage, the professional sings lead and first tenor, second tenor, and even falsetto. Alongside Classic Sounds he has been fortunate to have performed on "The Vinny Vella Show" and proudly filled stadiums across the country.

Media Contact:
GLO AGENCY
MICHAEL GLOVASKI
786-623-3911
[email protected]

SOURCE Dr. Gabriel Dassa


These press releases may also interest you

at 17:25
Talphera, Inc. , ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that the Board of Directors of Talphera has granted...

at 16:56
A paper published in the June edition of the Journal Diabetes demonstrates that C-peptide, a biomarker that indicates the production of insulin, is a validated surrogate endpoint, or predictor of clinical benefit, for clinical trials of...

at 16:28
?Patients Treated with ARIKAYCE Plus Macrolide-Based Background Regimen Had Meaningfully Greater Improvements in Respiratory Symptoms vs. Macrolide-Based Background Regimen Alone, As Measured By the QOL-B Respiratory Domain Instrument? ?QOL-B...

at 16:20
Jarrard Inc., a leading national healthcare strategic communications consultancy, has expanded by 10 percent, adding seven new professionals to address the increasing demand for its healthcare advisory services. The team now includes 81 full-time...

at 16:10
Pulse Biosciences, Inc. ("Pulse" or the "Company"), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced that the Company's Board of Directors has determined a new record...

at 16:10
Contineum Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with specific clinical impairments for the treatment of...



News published on and distributed by: